A Study to Examine the Effect of Particle Size on Bioequivalence and Bioavailability
NCT00517543
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
36
Enrollment
INDUSTRY
Sponsor class
Conditions
Chronic Obstructive Pulmonary Disease (COPD)
Rheumatoid Arthritis
Atherosclerosis
Interventions
DRUG:
GW856553
Sponsor
GlaxoSmithKline